Intellia Therapeutics NTLA
NASDAQ NTLA
$12.03 +0.61 (+5.34%)
At close: Sep 29, 2026 · 4:00 PM EDT

Intellia Therapeutics (NTLA) Operating Expenses (2015 - 2026)

Updated

Intellia Therapeutics (NTLA) recorded Operating Expenses of $120.42 million in Q2 2026, down 3.1% from $124.24 million a year earlier but up 4.2% from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) Operating Expenses (2015 - 2026) Analysis & Trends

On a TTM basis, Intellia Therapeutics' Operating Expenses came in at $482.99 million as of Jun 30, 2026, down 14.5% year-over-year; for FY2025, it was $508.66 million, down 14.1% from FY2024.

  • Annual Operating Expenses has a five-year compound annual growth rate of 21.2% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $592.14 million in FY2024 (+7.4%), $551.57 million in FY2023 (+8.1%), $510.29 million in FY2022 (+69.6%) and $300.9 million in FY2021 (+54.6%).
  • Quarterly Operating Expenses has ranged from $79.2 million in Q3 2021 to $155.5 million in Q1 2022 over the past five years.
  • On a year-over-year basis, Operating Expenses has declined for six consecutive quarters, with an average decline of 7.4% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 194.1% in Q1 2022, against a decline of 19.9% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $115.58 million (Q1 2026), $121.73 million (Q4 2025) and $125.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Intellia Therapeutics 1.60 Bn 1.60 Bn - 120.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 120.42 Mn
Mar 31, 2026 115.58 Mn
Dec 31, 2025 121.73 Mn
Sep 30, 2025 125.26 Mn
Jun 30, 2025 124.24 Mn
Mar 31, 2025 137.43 Mn
Dec 31, 2024 149.32 Mn
Sep 30, 2024 153.88 Mn
Jun 30, 2024 146.00 Mn
Mar 31, 2024 142.94 Mn
Dec 31, 2023 137.98 Mn
Sep 30, 2023 143.10 Mn
Jun 30, 2023 145.93 Mn
Mar 31, 2023 124.56 Mn
Dec 31, 2022 123.66 Mn
Sep 30, 2022 118.80 Mn
Jun 30, 2022 112.33 Mn
Mar 31, 2022 155.50 Mn
Dec 31, 2021 93.27 Mn
Sep 30, 2021 79.20 Mn
API Access

Intellia Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=NTLA&period=max&api_key=YOUR_API_KEY